Related references
Note: Only part of the references are listed.
Article
Pharmacology & Pharmacy
Benjamin M. King et al.
Summary: Zwitterionic polymers have been developed as coatings for gold nanoparticles to enhance stability and uptake in biological environments. These coated nanoparticles showed reduced aggregation, improved suspension stability, decreased protein adsorption, and increased cell uptake compared to uncoated particles after exposure to biological fluids. The differences in particle fate between serum and lung lavage fluid exposures suggest that fluid composition impacts particle behavior.
Review
Pharmacology & Pharmacy
D. Alzate-Correa et al.
Summary: The administration of cells as therapeutic agents is a new approach to treat diseases. Nanotechnology-driven cell therapies have the potential to overcome challenges related to efficacy, safety, and translational potential.
Review
Pharmacology & Pharmacy
Purva Khare et al.
Summary: The study found that LNPs can efficiently deliver siRNA to neurons with superior safety profile, indicating their potential application in neural cell therapy.
Article
Pharmacology & Pharmacy
Nhu Truong et al.
Summary: Nanoparticles are a highly promising drug delivery platform with potential applications in controlled drug release, improved targeting, and reduced toxicity. The study developed and optimized a microfluidic method for producing immunomodulatory nanoparticles (iNPs) with anti-inflammatory properties, demonstrating a reproducible strategy for inflammation management.
Article
Pharmacology & Pharmacy
Mairead K. Heavey et al.
Summary: This study investigates the use of genetically engineered microbes to deliver therapeutic proteins to the gastrointestinal tract and examines how to control their dynamics within the gut. Three methods are established to modulate the pharmacokinetics of the engineered fungi system, which will be crucial in controlling downstream therapeutic response in this new drug delivery modality.
Review
Pharmacology & Pharmacy
Zhicheng Wang et al.
Summary: The complement cascade poses a significant barrier to targeted drug delivery and nanomedicine by opsonizing nanocarriers and leading to deleterious effects. Material properties of nanocarriers can impact complement activation, and current and future strategies are being developed to control complement and unlock the potential of nanomedicine.
Review
Pharmacology & Pharmacy
Neil Patel et al.
Summary: Cardiovascular disease caused by atherosclerosis is a major global health concern. Exosomes secreted by various cell types play a crucial role in the development of atherosclerosis and have both atherogenic and atheroprotective functions. Enhancing the therapeutic potential of atheroprotective exosomes through drug loading and surface modification is a promising approach, but current challenges exist in exosome engineering for therapeutic applications.
Review
Pharmacology & Pharmacy
Dhruv Varshney et al.
Summary: Toll-like receptors (TLRs) play a crucial role in cancer immunotherapy, with TLR7 and TLR8 being identified as potential therapeutic targets. Despite challenges such as poor drug solubility and systemic toxicity, biomaterial-based drug delivery systems have shown promise in enhancing the efficacy of TLR7/8 agonists. Additionally, combining TLR7/8 agonists with other therapies, such as checkpoint inhibitors and cancer vaccines, has demonstrated impressive anti-cancer effects.
Article
Pharmacology & Pharmacy
Lauren E. Waggoner et al.
Summary: Peptides play a key role in controlling the pharmacokinetic profiles of nanoparticles, particularly in the context of traumatic brain injury (TBI). The physicochemical properties of peptides on nanoparticle surfaces can significantly impact their distribution and accumulation in off-target organs, with positively charged peptides leading to increased accumulation in non-target organs but decreased accumulation in the injured brain. Understanding these relationships is crucial for the development of nanoparticle-based TBI therapeutics and has broader implications for nanotherapeutic design.
